Your browser doesn't support javascript.
loading
Mercaptopyrimidine-templated gold nanoclusters for antithrombotic therapy.
Dai, Jianghong; Lei, Jiaojiao; Zhang, Tianyan; You, Jingcan; Qin, Dalian; Wu, Ya; Liu, Yong; Zheng, Youkun.
Affiliation
  • Dai J; Basic Medicine Research Innovation Center for Cardiometabolic Diseases, Ministry of Education, Southwest Medical University, Luzhou 646000, China. lyong74@163.com.
  • Lei J; Department of Vascular Surgery, The Affiliated Hospital, Southwest Medical University, Luzhou 646000, China.
  • Zhang T; Basic Medicine Research Innovation Center for Cardiometabolic Diseases, Ministry of Education, Southwest Medical University, Luzhou 646000, China. lyong74@163.com.
  • You J; Department of Pharmacology, School of Pharmacy, Southwest Medical University, Luzhou 646000, China.
  • Qin D; Basic Medicine Research Innovation Center for Cardiometabolic Diseases, Ministry of Education, Southwest Medical University, Luzhou 646000, China. lyong74@163.com.
  • Wu Y; Department of Pharmacology, School of Pharmacy, Southwest Medical University, Luzhou 646000, China.
  • Liu Y; Basic Medicine Research Innovation Center for Cardiometabolic Diseases, Ministry of Education, Southwest Medical University, Luzhou 646000, China. lyong74@163.com.
  • Zheng Y; Department of Pharmacology, School of Pharmacy, Southwest Medical University, Luzhou 646000, China.
J Mater Chem B ; 12(7): 1775-1781, 2024 Feb 14.
Article in En | MEDLINE | ID: mdl-38284142
ABSTRACT
Here we report for the first time that mercaptopyrimidine-templated gold nanoclusters (DAMP-AuNCs) can be used as a novel anticoagulant candidate for the design of antithrombotic drugs. Anticoagulant mechanisms revealed that DAMP-AuNCs significantly inhibited thrombus formation by interacting with fibrinogen. Carrageenan-induced mice tail thrombosis model experiments showed that DAMP-AuNCs had antithrombotic efficacy comparable to heparin in vivo. More importantly, these ultrasmall AuNCs possess excellent blood compatibility and only induce negligible bleeding side effects. Our study is a successful attempt at developing novel antithrombotic agents with high biosafety.
Subject(s)

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Fibrinolytic Agents / Gold Type of study: Prognostic_studies Limits: Animals Language: En Journal: J Mater Chem B Year: 2024 Document type: Article Affiliation country: China Country of publication: United kingdom

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Fibrinolytic Agents / Gold Type of study: Prognostic_studies Limits: Animals Language: En Journal: J Mater Chem B Year: 2024 Document type: Article Affiliation country: China Country of publication: United kingdom